NCT04581772View on ClinicalTrials.gov

A Study to Evaluate the Bioavailability and Safety of DNL343 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

December 23, 2020

Primary Completion Date

June 4, 2021

Study Completion Date

June 4, 2021

Conditions
Healthy Volunteers
Interventions
DRUG

DNL343

Multiple oral doses

DRUG

Placebo

Single oral dose

DRUG

DNL343

Single oral dose

Trial Locations (1)

Unknown

Auckland Clinical Studies Ltd., Grafton

Sponsors
All Listed Sponsors
lead

Denali Therapeutics Inc.

INDUSTRY